Albany, NY, March 31, 2016 -- The recent report, titled “Intracranial Pressure Monitors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, from Transparency Market Research (TMR) delivers a 360-degree view of the market. According to this report, the global intracranial pressure monitors market will progress at a 6.40% CAGR during the forecast period from 2015 to 2023. In 2014, the global intracranial pressure monitors market was estimated at US$210.5 mn and by 2023, the market will be worth US$350.5 mn.
Avail Industry Research Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6445
Intracranial pressure monitors are medical devices supporting the measurement of the pressure inside the skull during critical care. The global intracranial pressure monitors market is driven by the sustained rise in the incidence of traumatic injuries. Furthermore, the elevated health care expenditure worldwide, along with the rising occurrence of stroke incidents globally, will drive the global intracranial pressure monitors market. On the other hand, infections arising from the invasive nature of intracranial pressure monitors will challenge the global intracranial pressure monitors market’s growth.
By type, the global intracranial pressure monitors market is segmented into air pouch devices, strain gauge transducers, fiberoptic monitors, and external ventricular drain (EVD). The EVD segment held the largest share (more than 35%) in the global intracranial pressure monitors market in 2014. EVDs are easy to use and extremely affordable, driving their demand in the market. Furthermore, EVD can be re-zeroed during any point of time, further driving their popularity among consumers. On the other hand, the air pouch devices segment will enjoy the highest CAGR during the forecast period due to the low zero-drift features offered by air pouch devices.
Browse Market Research Report at http://www.transparencymarketresearch.com/intracranial-pressure-monitors-market.html
Application-wise, the global intracranial pressure monitors market is divided into subarachnoid hemorrhage, meningitis, intracerebral hemorrhage, traumatic brain injury, and others. The traumatic brain injury segment held the largest share in the global intracranial pressure monitors market in 2014. Factors such as the rising incidence of traffic-related accidents, violence, and sports injuries are fuelling this segment. On the basis of end use, the global intracranial pressure monitors market is segmented into hospitals and trauma centers. The trauma centers segment led the global intracranial pressure monitors market in 2014 due to the round-the-clock availability of trained healthcare providers and growing number of critically ill patients.
Region-wise, the global intracranial pressure monitors market is classified into Asia Pacific, Europe, North America, and Rest of the World (RoW). North America held more than 50% of the global intracranial pressure monitors market. The North America intracranial pressure monitors market benefits from the elevated awareness of consumers, improved healthcare infrastructure, and high acceptance of advanced monitoring equipment.
Browse Research Article at http://www.transparencymarketresearch.com/article/intracranial-pressure-monitors-market.htm
Players in the global intracranial pressure monitors market will benefit from the shift from invasive to non-invasive monitoring devices. Emerging economies also offer good sustained growth opportunities to companies. Some of the key players operating in the global intracranial pressure monitors market are Spiegelberg, Raumedic, Medtronic, Integra LifeSciences, HeadSense Medical, Haying Medical, and Codman & Shurtleff.
Other Reports by TMR:
- Knee Cartilage Repair Market: http://www.transparencymarketresearch.com/knee-cartilage-repair-market.html
- Dermatology Diagnostic Devices and Therapeutics Market: http://www.transparencymarketresearch.com/dermatology-diagnostic-devices-therapeutics-market.html
- Blood Gas and Electrolyte Analyzer Market: http://www.transparencymarketresearch.com/blood-gas-electrolyte-analyzers.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 



